FACULTY AND PLANNING COMMITTEE

FACULTY

Chair:
Perry Fine, MD
University of Utah
Salt Lake City, UT

Faculty:

Stephen Connor, PhD
Capital Hospice
Fairfax, VA

Mitchell Cohen, MD
Jefferson Medical College
Philadelphia, PA

Barry Gidal, PharmD, RPh
University of Wisconsin-Madison
Madison, WI

Robert Norman Harden, MD
Rehabilitation Institute of Chicago
Chicago, IL

J. Cameron Muir, MD
Capital Hospice and Capital Palliative Care
Falls Church, VA

Scott Fishman, MD
University of California, Davis
Sacramento, CA

Christopher Gharibo, MD
NYU Langone Medical Center
New York, NY

Howard Smith, MD
Albany Medical Center
Albany, NY

Biostatisticians:
David Bradshaw, PhD
University of Utah

Additional Planning Committee Members

• Arlene Bradford, University of Michigan Medical School
• Mindi Daiga, The Academy for Continued Healthcare Learning
• Lisa Keckich, The Academy for Continued Healthcare Learning
• Kelly Kuras, The Academy for Continued Healthcare Learning
• Helen Tselentis, The Academy for Continued Healthcare Learning
• Tana O’Lone, University of Michigan Medical School
• Daniel Clauw, MD, University of Michigan Medical School

DISCLOSURE

Current guidelines require that participants in CME/CE activities be made aware of all affiliations or financial interests that may be perceived as influencing the content of an educational activity. The Academy for Continued Healthcare Learning ensures that all faculty and staff involved in the planning, development, and implementation of this activity disclose all potential conflicts of interest and resolve them before the CME/CE activity occurs. Disclosures are provided below:

Perry Fine, MD, (Chair) Type of financial relationship(s):
Consultant: Ameritox, Cephalon, Covidien, Johnson & Johnson, Meda Pharmaceuticals, Pfizer, and Purdue Pharma
Speakers' Bureau: Ortho-McNeil and Pricara

Christoper Gharibo, MD, (Faculty) Type of financial relationship(s):
Consultant: King Pharmaceuticals

Daniel Clauw, MD, (Content Reviewer) Type of financial relationship(s):
Consultant: Pfizer, Lilly, Forest, Cypress, Biosciences, Pierre Fabre, UCB, Jazz Pharmaceuticals, Merck

Barry Gidal, PharmD, (Faculty) Type of financial relationship(s):
Consultant: GlaxoSmithKline and UCB
Speakers’ Bureau: GlaxoSmithKline and UCB
Grant/Research Support: GlaxoSmithKline and UCB

Robert Norman Harden, MD, (Faculty) Type of financial relationship(s):
Consultant: Biomed & Astellas
Grant/Research Support: Covidien, Forest, GlaxoSmithKline and Pfizer

The following faculty have no relevant financial relationships with commercial interests: Mitchell Cohen, David Bradshaw, Stephen Connor, Scott Fishman, J. Cameron Muir, Howard Smith

All Planning Committee members with The Academy for Continued Healthcare Learning and University of Michigan Medical School staff members have no relevant affiliations or financial relationships to disclose.